Skip to content
Unclaimed
Discovery tool, not advice. Every figure is the published rule, not a decision on your case.
Grants

CARB-X (Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator)

CARB-X funding solicitations

Status

Opens 2026-11-10

Date published by the funder.

Opens soon
Amount
Not published

Non-dilutive milestone-based awards for pre-clinical and early clinical antibacterial products. CARB-X has invested USD 506 million across 124 projects in 14 countries; individual awards have commonly ranged from a few hundred thousand to over USD 10 million including options.

Funder

CARB-X, hosted by Boston University

ppp · supranational

Deadline: One call a year — 2026 funding round: applications via CARB-X Portal open 10 November 2026 and close 23 November 2026 (23:59 ET). Themes include direct-acting Gram-negative therapeutics.

Your odds
Not published

This funder does not publish a success rate. We rank it using the rate observed across similar programmes and label it as an estimate rather than implying we know.

Effort
quick

Quick — mostly identity and bank details.

Who can apply

Open to small companies, biotechs and academic spinouts worldwide working on antibiotics, preventatives (vaccines, microbiome), rapid diagnostics and other products against drug-resistant bacteria.

Apply on the funder's site

Source. https://carb-x.org/apply/funding-themes/

"Return here on 10 November to submit your application in the CARB-X Portal."

Last checked against the official page on 5 October 2026

Source: carb-x.org

Report an error Something wrong or out of date? Tell us.

Similar programmes

Paid, separate from Unclaimed

Want a human to review your application?

Involve Consulting can help — a paid expert-review service run by the same person behind Unclaimed, entirely separate from this free check. A flat fee, agreed up front; never a cut of what you receive.

Talk to Involve Consulting